The financing extends DrFirst’s strategic relationship with SunTrust Banks, a partnership which initially began in 2015.
The new funds will support the expansion of the company’s operational and development efforts for initiatives targeting the pharma and consumer sectors.
Led by G. Cameron Deemer, president, DrFirst is a provider of e-prescribing, price transparency, and medication management solutions, which enables stakeholders across the healthcare industry to use comprehensive real-time data and connectivity to increase their patient safety ratings, efficiency, and profitability.
Today, more than 220,000 healthcare professionals, 75,000 prescribers, and hundreds of electronic health record (EHR) vendors use the company’s software solutions to improve clinical workflows, expedite secure collaboration across a patient’s care team and drive better health outcomes.
DrFirst’s integrated technologies include its electronic prescribing platform, a comprehensive medication history, clinically specialized secure messaging, and patient medication adherence monitoring and benefits checking.
Also, the company offers e-prescribing for controlled substances (EPCS).
FinSMEs
24/04/2019